Search research articles
Contact Us
Filters
Showing results (51-60 of 81) with videos related to
Page
of 9
Sort By:
Infectious Disease Reports
|
June 1, 2022
Implementing Early Phase Treatments for COVID-19 in Outpatient Settings: Challenges at a Tertiary Care Center in Italy and Future Outlooks
Tommaso Manciulli, Filippo Lagi, Anna Barbiero, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
May 7, 2020
Early experience of an infectious and tropical diseases unit during the coronavirus disease (COVID-19) pandemic, Florence, Italy, February to March 2020
Filippo Lagi, Matteo Piccica, Lucia Graziani, et al.
HIV Medicine
|
July 28, 2021
Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohort
Massimiliano Fabbiani, Barbara Rossetti, Arturo Ciccullo, et al.
Internal and Emergency Medicine
|
February 28, 2023
Characteristics of COVID-19 vaccinated and unvaccinated patients admitted to Careggi University Hospital, Florence, Italy
Riccardo Paggi, Anna Barbiero, Tommaso Manciulli, et al.
Medicine
|
November 3, 2021
Has COVID-19 changed the approach to HIV diagnosis?: A multicentric Italian experience
Maria Mazzitelli, Arturo Ciccullo, Gianmaria Baldin, et al.
The Journal of Antimicrobial Chemotherapy
|
May 15, 2026
'Leaving no stones unturned': up to 10 years results on the effectiveness, tolerability and metabolic safety of dolutegravir+lamivudine (DTG+3TC) as a switch regimen in the ODOACRE cohort
Arturo Ciccullo, Gianmaria Baldin, Adriana Cervo, et al.
International Journal of STD & AIDS
|
June 12, 2025
Exploring mpox vaccination uptake and tolerability among people living with HIV: A study in an infectious disease unit in Italy
Samuele Gaggioli, Giuseppe Formica, Valentina Petrini, et al.
Viruses
|
September 27, 2025
Virological Effectiveness of Dolutegravir Plus Darunavir in People with Multi-Drug-Resistant HIV: Data from the PRESTIGIO Registry
Filippo Lagi, Michele Bellomo, Riccardo Lolatto, et al.
Antiviral Therapy
|
September 23, 2017
Viro-immunological response of drug-naive HIV-1-infected patients starting a first-line regimen with viraemia >500,000 copies/ml in clinical practice
Maria Mercedes Santoro, Domenico Di Carlo, Daniele Armenia, et al.
Journal of Travel Medicine
|
August 27, 2014
Imported dengue fever in Tuscany, Italy, in the period 2006 to 2012
Filippo Lagi, Lorenzo Zammarchi, Marianne Strohmeyer, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 81) with videos related to
Sort By:
Page
of 9
Infectious Disease Reports
|
June 1, 2022
Implementing Early Phase Treatments for COVID-19 in Outpatient Settings: Challenges at a Tertiary Care Center in Italy and Future Outlooks
Tommaso Manciulli, Filippo Lagi, Anna Barbiero, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
May 7, 2020
Early experience of an infectious and tropical diseases unit during the coronavirus disease (COVID-19) pandemic, Florence, Italy, February to March 2020
Filippo Lagi, Matteo Piccica, Lucia Graziani, et al.
HIV Medicine
|
July 28, 2021
Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohort
Massimiliano Fabbiani, Barbara Rossetti, Arturo Ciccullo, et al.
Internal and Emergency Medicine
|
February 28, 2023
Characteristics of COVID-19 vaccinated and unvaccinated patients admitted to Careggi University Hospital, Florence, Italy
Riccardo Paggi, Anna Barbiero, Tommaso Manciulli, et al.
Medicine
|
November 3, 2021
Has COVID-19 changed the approach to HIV diagnosis?: A multicentric Italian experience
Maria Mazzitelli, Arturo Ciccullo, Gianmaria Baldin, et al.
The Journal of Antimicrobial Chemotherapy
|
May 15, 2026
'Leaving no stones unturned': up to 10 years results on the effectiveness, tolerability and metabolic safety of dolutegravir+lamivudine (DTG+3TC) as a switch regimen in the ODOACRE cohort
Arturo Ciccullo, Gianmaria Baldin, Adriana Cervo, et al.
International Journal of STD & AIDS
|
June 12, 2025
Exploring mpox vaccination uptake and tolerability among people living with HIV: A study in an infectious disease unit in Italy
Samuele Gaggioli, Giuseppe Formica, Valentina Petrini, et al.
Viruses
|
September 27, 2025
Virological Effectiveness of Dolutegravir Plus Darunavir in People with Multi-Drug-Resistant HIV: Data from the PRESTIGIO Registry
Filippo Lagi, Michele Bellomo, Riccardo Lolatto, et al.
Antiviral Therapy
|
September 23, 2017
Viro-immunological response of drug-naive HIV-1-infected patients starting a first-line regimen with viraemia >500,000 copies/ml in clinical practice
Maria Mercedes Santoro, Domenico Di Carlo, Daniele Armenia, et al.
Journal of Travel Medicine
|
August 27, 2014
Imported dengue fever in Tuscany, Italy, in the period 2006 to 2012
Filippo Lagi, Lorenzo Zammarchi, Marianne Strohmeyer, et al.
Page
of 9